Nutra Pharma Corp.
Bringing Healthcare Solutions to the World
 
Drug Discovery
Overview
Conditions
Intellectual Property
Research
R&D Pipeline
Cobroxin
Drug Development
R&D Pipeline
Nutra Pharma is developing an innovative pipeline of biopharmaceutical products
E-Alerts
Signup to receive news and announcements from Nutra Pharma:
First Name:
Last Name:
Email:
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.

Conditions

Nutra Pharma, through its subsidiary ReceptoPharm, is taking on some of the world's most difficult diseases including Multiple Sclerosis, HIV/AIDS, Adrenomyeloneuropathy, and Herpes.

RPI-MN: Modified Cobra Venom for Viral Diseases

Herpes
Herpes is a group of related diseases marked by the development of blisterlike sores on the skin or mucous membranes of the body.
 
 
Human Immunodeficiency Virus (HIV / AIDS)
The Human Immunodeficiency Virus (HIV) is the virus that causes AIDS, a debilitating and deadly disease of the human immune system. The World Health Organization (WHO) estimates that 20 million people have died from AIDS since 1981. It is estimated that at the end of 2001, there were more than 40 million people worldwide infected with HIV and living with the virus or AIDS.
 

RPI-78M: Modified Alpha Cobratoxin for Autoimmune Diseases

Adrenomyeloneuropathy (AMN)
Adrenomyeloneuropathy (AMN) is a rare inherited metabolic disorder that effects approximately 20,000 people globally. Its symptoms are very similar to those of progressive Multiple Sclerosis (MS).
Additional Information: AMNHelp
 
 
Multiple Sclerosis (MS)
Multiple Sclerosis (MS) is a chronic autoimmune disease of the central nervous system causing muscular weakness, loss of coordination, and speech and visual disturbances.
 
Quick Nav
Nyloxin // Chronic Pain Relief
Read about Jeff Gottfurcht, the first rheumatoid arthritis sufferer to conquer Everest, in Musculoskeletal Health a special section of the Washington Post.
 

 

 
Recent News
 
June 10, 2014
Nutra Pharma Announces Contracts for Nyloxin Television Commercials


January 07, 2014
Nutra Pharma Announces the First Shipments and Product Delivery to MyNyloxin.com Independent Entrepreneurs


December 02, 2013
Nutra Pharma Finalizes Exclusive Network Marketing Distribution Agreement for Nyloxin


 
 
Announcements
Click here to view a Letter to Shareholders from the Company's CEO, Rik J Deitsch.
 
 
Facebook   Twitter
 
NPC
Privacy Policy Code of Ethics